NasdaqCM - Delayed Quote • USD
Molecular Templates, Inc. (MTEM)
At close: April 24 at 4:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 212.87k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LALANDE KEVIN M Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 1.90 per share. | Indirect | 332,500 | Apr 2, 2024 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.47 per share. | Direct | 2,000,000 | Jul 17, 2023 |
| KIM JASON S President | Conversion of Exercise of derivative security at price 0.71 per share. | Direct | 8,583 | Jul 7, 2022 |
| MCLENNAN SEAN Chief Financial Officer | Purchase at price 0.82 per share. | Direct | 24,477 | Jun 16, 2022 |
| LALANDE KEVIN M Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.87 - 0.91 per share. | Indirect | 198,380 | Jun 15, 2022 |
| SHV MANAGEMENT SERVICES, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.87 - 0.91 per share. | Indirect | 198,380 | Jun 15, 2022 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.17 per share. | Indirect | 234,000 | May 16, 2022 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | May 16, 2022 |
| POMA ERIC E. PH.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 0.71 per share. | Direct | 24,251 | Apr 27, 2022 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.04 per share. | Indirect | 807,180 | Jan 6, 2022 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.04 per share. | Indirect | 807,180 | Jan 6, 2022 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.00 per share. | Indirect | 4,500,000 | Sep 21, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.00 per share. | Indirect | 4,500,000 | Sep 21, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.13 per share. | Indirect | 613,000 | Sep 16, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.13 per share. | Indirect | 613,000 | Sep 16, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.00 - 7.09 per share. | Direct | 1,091,656 | Jul 27, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.00 - 7.09 per share. | Direct | 1,091,656 | Jul 27, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.96 - 7.13 per share. | Direct | 1,722,502 | Jul 20, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.96 - 7.13 per share. | Direct | 1,722,502 | Jul 20, 2021 |
| POMA ERIC E. PH.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 0.71 per share. | Direct | 2,530 | Jul 6, 2021 |
| KIM JASON S President | Sale at price 8.36 per share. | Direct | 23,157 | Jun 28, 2021 |
| KIM JASON S President | Conversion of Exercise of derivative security at price 0.71 per share. | Direct | 22,747 | Jun 28, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.08 per share. | Indirect | 329,941 | Apr 19, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.08 per share. | Indirect | 329,941 | Apr 19, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.62 per share. | Indirect | 1,292,655 | Apr 15, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.62 per share. | Indirect | 1,292,655 | Apr 15, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.81 - 8.37 per share. | Indirect | 2,037,010 | Apr 14, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.81 - 8.37 per share. | Indirect | 2,037,010 | Apr 14, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.02 - 8.23 per share. | Indirect | 2,340,463 | Apr 12, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.02 - 8.23 per share. | Indirect | 2,340,463 | Apr 12, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.22 - 8.24 per share. | Indirect | 4,114,820 | Apr 8, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.22 - 8.24 per share. | Indirect | 4,114,820 | Apr 8, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.44 per share. | Indirect | 1,887,100 | Apr 5, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.44 per share. | Indirect | 1,887,100 | Apr 5, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.45 per share. | Direct | 915,848 | Mar 29, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.45 per share. | Direct | 915,848 | Mar 29, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.29 - 11.48 per share. | Indirect | 3,513,866 | Feb 24, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.29 - 11.48 per share. | Indirect | 3,513,866 | Feb 24, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.65 per share. | Direct | 14,999,990 | Feb 18, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.65 per share. | Direct | 14,999,990 | Feb 18, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.69 per share. | Indirect | 935,344 | Feb 1, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.69 per share. | Indirect | 935,344 | Feb 1, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.94 per share. | Indirect | 955,000 | Jan 29, 2021 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.94 per share. | Indirect | 955,000 | Jan 29, 2021 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.18 - 8.62 per share. | Indirect | 3,727,441 | Dec 10, 2020 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.18 - 8.62 per share. | Indirect | 3,727,441 | Dec 10, 2020 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.05 - 9.16 per share. | Indirect | 1,456,616 | Nov 10, 2020 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.05 - 9.16 per share. | Indirect | 1,456,616 | Nov 10, 2020 |
| BIOTECH TARGET N.V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.33 - 10.86 per share. | Indirect | 4,734,190 | Nov 6, 2020 |
| BIOTECH TARGET N V Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.33 - 10.86 per share. | Indirect | 4,734,190 | Nov 6, 2020 |
Related Tickers
ARMP Armata Pharmaceuticals, Inc.
2.5000
-1.19%
EPIX ESSA Pharma Inc.
6.25
-2.34%
BION.SW BB Biotech AG
41.20
-0.60%
APTCF Advanced Proteome Therapeutics Corporation
0.0002
0.00%
CRPOF Ceapro Inc.
0.1845
0.00%
BIO.DE Biotest Aktiengesellschaft
41.60
0.00%
ARGX.VI argenx SE
349.70
-0.23%
AIM AIM ImmunoTech Inc.
0.4300
+1.06%
QTTB Q32 Bio Inc.
26.59
+4.27%
PCIB.OL PCI Biotech Holding ASA
1.6940
-0.12%